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1. Introduction  
A significant body of knowledge has established that stressors in early life have long-term 
health consequences on the adult organism. This has given rise to the Developmental 
Origins of Health and Adult Disease (DOHAD) hypothesis. Among the several broad 
themes that have emerged from the clinical and experimental investigations into the 
DOHAD hypothesis; perhaps none is as intriguing as the role of biological sex and sex 
hormones in the progression and development of adult diseases. Despite the significant 
progress in recent years, many uncertainties remain with respect to the roles of biological 
sex and gonadal steroids in the progression of human diseases in general, and in the 
mechanisms underlying sex differences in developmental programming in particular.  
While sexual dimorphism is widely recognized in the progression of many diseases (e.g. 
cardiovascular), it appears that the primary pathways leading to these differences exert 
distinct influences during fetal and adult life. The mechanisms by which biological sex 
contributes to these processes is a rapidly expanding area of investigation drawing upon 
studies interrogating systems at the molecular, cellular and whole organism physiological 
levels. From these investigations several intriguing hypotheses have been proposed. These 
include developmental programming due to: 1) endocrine disruption resulting from 
exogenous sex steroids and/or analogs or nutritional stress during development; 2) 
chromosomal regulation of sex dimorphism in the transcriptome of mammalian tissues; and 
3) sex specific responses to stressors during fetal life. The goal of this chapter is to place into 
perspective the current body of knowledge in the rapidly growing area of sex differences in 
developmental programming with a primary focus on cardiovascular diseases. 
2. Periods of susceptibility to developmental programming  
Developmental programming can be defined as the response by the developing organism to 
specific stimuli during critical periods of organogenesis that results in persistent effects on 
the adult phenotype. It is now recognized as an important determinant of adult health. 
Acceptance and understanding of this concept derives from human epidemiological studies 
suggesting that many metabolic diseases such as cardiovascular disease (Barker, 1993), 
chronic kidney disease (Li et al., 2007), type II diabetes mellitus (Hovi et al., 2007;Hofman et 
al., 1997), and hypertension (Roseboom et al., 2001) are associated with low birth weight. 
Since developing organisms pass more physiological benchmarks prior to birth than during 
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any other time in life, it is not surprising that deviations in the timing or nature of these 
developmental steps have functional consequences in later life. Hence, it is vitally important 
to understand early life gene-environment interactions that can increase predisposition to 
adult disease. Figure 1 provides an overview of the timing of the susceptibilities for various 
organs systems and processes in developmental programming. 
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Fig. 1. Organogenesis and Maturation Disruption. Timeline depicts separate stages of 
mammalian organ development and maturation and the relative sensitivity to various 
programming stimuli. Listed above are necessary processes during this period for normal 
growth and the activity (light blue). At the top are the perturbations that can interfere with 
proper development. 
2.1 Embryonic development 
Susceptibility to programming events begins very early in life and surprisingly sex differences 
are already present. The transcriptome of male and female pre-implantation embryos differ 
such that several genes located on the X chromosome are more expressed in bovine and 
human female versus male embryos (Gutierrez-Adan et al., 2000;Taylor et al., 2001;Wrenzycki 
et al., 2002;Peippo et al., 2002) while autosomal genes expressed in trophoblast cells, such as 
those for interferon-Ǆ (Larson et al., 2001), human choriogonadotropic hormone (Haning, Jr. et 
al., 1989), and numerous other imprinted genes (Paldi et al., 1995;Kovtun et al., 2000;Durcova-
Hills et al., 2004) are also not expressed or methylated the same across the sexes. Morphological 
differences exist as well; male and female embryos differ in rates of development as early as 
the first few days post-fertilization. Bovine (Avery et al., 1992;Yadav et al., 1993),  murine 
(Valdivia et al., 1993) and ovine embryos (Bernardi & Delouis, 1996) produced in vitro often fall 
into fast-cleaving and slow-cleaving groups that are predominantly male and female, 
respectively. Interestingly, Sood et al. reported a sex dichotomy in the genes expressed in male 
and female placentas (Sood et al., 2006) using microarray analysis and identified genes in 
villous samples such as JAK1, IL2RB, Clusterin, LTBP, CXCL1, and IL1RL1 that were 
expressed at higher levels in female placentas.  
2.2 Fetal development  
The fetal period is a critical time for organogenesis. As gestation progresses and the embryo 
becomes a fetus, the sex dimorphism of early development re-appears around mid-gestation 
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as male fetuses become larger than age-matched females (Hindmarsh et al., 2002;Crawford et 
al., 1987;Parker et al., 1984). From clinical and experimental studies we know that this size 
difference persists to term (Hindmarsh et al., 2002;Parker et al., 1984;Gilbert et al., 
2007a;Gilbert et al., 2006a). Underlying these morphological differences are specific sex 
related differences in endocrinology and metabolism.  While androgens are recognized for 
their role in male maturation, they are also essential to development of the female fetus. 
Production of androgens in both the ovaries and the adrenal cortex in females is essential to 
folliculogenesis and mammary development. Levels below the required amount for normal 
development have been shown to diminish the development of the tissues aforementioned. 
Exposure of female fetuses to androgens may not necessarily disrupt normal development 
of the ovaries, but may result in altered expression of steroidogenic proteins (Hogg et al., 
2011). Increased androgens are also associated with female fetuses developing male-like 
sexual behavior, increased aggression, delayed vaginal opening (Meisel & Ward, 1981).  
Sex differences at the molecular level also persist from embryonic into fetal life. Baserga et al. 
have reported that gestation in the rat cyclooxygenase-2 (COX-2) levels were higher in the 
female than the male kidney at day of gestation (DG) 8, although not significantly increased 
at DG 21. In contrast, 11ǃ-Hydroxysteroid Dehydrogenase 2 (11ǃ-HSD2) levels were higher 
in the male control kidney at DG 21. Both of these gene products play important roles in 
renal function and alterations in either could have developmental and/or functional effects 
in the kidney (Baserga et al., 2007b). Similarly, sex differences have also been reported in the 
ontogeny of gene expression in the renal RAS (Gilbert et al., 2007a).  
Similar to the kidney, the mammary gland undergoes discrete phases of development. 
However, in contrast to the kidney, the mammary has important developmental phases that 
extend into adulthood. In early pregnancy, the processes of fetal mammary development are 
thought to occur independently of influences from systemic hormones (Hennighausen & 
Robinson, 2001). After mid-gestation, placental hormones enter fetal circulation and initiate 
canalization of the early ductal system. It is during this period that exposure to endocrine 
mimetics may exert an influence on subsequent risk of breast cancer in the offspring (Xue & 
Michels, 2007). While the origin and the purpose of these sex differences in fetal 
development remain unclear, it may simply reflect different trajectories of fetal development 
between the sexes; however, this may also underlie sex differences in developmental 
programming.  
2.3 Post-natal 
It has long been observed that growth restricted fetuses which develop metabolic syndrome 
often experience “catch-up growth” and surpass normal birth weight controls (Hales & 
Ozanne, 2003). While it is clear that catch-up growth plays a role in the manifestations of 
developmental programming it has been difficult to identify the specific peri-natal vs. post-
natal influences involved. Disordered vascular function is thought to contribute to 
programming of cardiovascular health but the cause and effect relationships remain 
uncertain (Martin et al., 2000;Leeson et al., 2001;Goodfellow et al., 1998). There are recognized 
sex differences in arterial pressure and the progression of renal disease, both of which are 
thought to involve interactions of the renin angiotensin system and sex steroids (Sandberg & 
Ji, 2003;Silva-Antonialli et al., 2004). Most current evidence points to sex steroids as the most 
important factor influencing sex differences in post-natal cardiovascular function.   
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In contrast to organs such as the kidney that complete development in utero, several 
reproductive organs such as the mammary undergo significant developmental changes 
during post-natal life and sometimes well into adulthood. A significant portion of 
mammary development begins at puberty and continues throughout an individual’s 
reproductive years (Hinck & Silberstein, 2005) and renders this particular organ to more 
critical periods susceptible to programming influences. Aberrant signaling during these 
phases may initiate abnormal growth of the ductal epithelium, possibly resulting in 
alterations in risk for subsequently developing mammary cancer. 
Interestingly, Wlodek, et al. found that uteroplacental insufficiency, via uterine restriction in 
rats, resulted in reduced alveolar proliferation (Wlodek et al., 2009). We have reported that 
growth restricted female rats from hypertensive mothers have a much higher incidence of 
mammary tumors when exposed to N-nitroso-N-methylurea than normal birthweight 
control rats (Gingery et al., 2011). Thus, differentiation events of the mammary epithelium 
occurring mid- to late-gestation may provide a substrate sensitive to sub-optimal 
intrauterine conditions or environmental exposures that could set the stage for subsequent 
development of cancer. 
The transcriptome continues to display sex differences in adulthood, such as in differences 
in expression of mRNA for osmoregulatory, drug and steroid metabolizing proteins in the 
murine kidney and liver (Rinn et al., 2004). It is therefore not unreasonable to hypothesize 
sex differences exist within a molecular framework and that there are many potential 
avenues, from embryonic life on into adulthood, through which sex differences may interact 
with developmental programming stimuli to result in sex specific alterations.  
3. Endocrine disruption 
It has become nearly axiomatic that endocrine signaling by gonadal steroids like estradiol 
and testosterone are important contributors to the development and maintenance of long-
term health and/or disease. Endocrine disruption generally occurs as a consequence of one 
or more of four main characteristics of the compound under study: agonist, antagonist, 
modification, and/or altering synthesis (Derfoul et al., 2003). Some compounds can have a 
pleiotropic effect in which at least two signaling pathways known to be independent from 
each other are impacted. Moreover, endogenous sexual hormones and mimetics include: 
estrone, estriol, estradiol, human chorionic gonadotropin, testosterone, progesterone, 
prostaglandins, and several other estrogens and androgens. While endocrine disruptors are 
traditionally considered to be environmental pollutants, there are numerous physiological 
stressors that may generate disturbances of endocrine signaling pathways. Further, in Table 
1 we highlight the main classes of steroidogenic endocrine disruptors and the manners in 
which they become accessible to organisms. To this end, we have considered a variety of 
physiological models under the general theme of endocrine disruption. 
3.1 Endogenous hormones/mimetics 
Females on average are at lesser of a risk for cardiovascular disease during the 
premenopausal state, but significantly are at increased risk for cardiovascular and renal 
disease after menopause, nearing comparable rates to male disease development (Gilbert & 
Nijland, 2008;Sakemi et al., 1995). In adult growth-restricted females, an ovariectomy can 
lead to an increase in renal-induced hypertension, compared to subjects with the ovaries still 
intact(Ojeda et al., 2007a). These observations allude to the idea that estrogens have a cardiac 
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Sex Hormone 
Disruption
Reported Mimetics
Reported Conduits of 
Exposure
Estrogens
Polychlorinated (PCB) and 
polybrominated (PBB) biphenyls, 
dichlorodiphenyltrichloroethane 
(DDT), Dichlordiphenyldichloro-
ethylene (DDE), methoxychlor, 
diethylstilbestrol (DES), 
alkylphenols, cadmium, bisphenyl-
A (BPA). 
Dielectric fluids and electronics; 
hard plastics; pesticides; 
insecticides; synthetic estrogens; 
sewage degradation, batteries 
and television screens; plastics 
and dental sealants
Androgens
Kepone , procymidone, 
dichlorodiphenyldichloroethylene
(DDE), vinclosolin, 2,3,7,8-
tetrachlorodibenzodioxin (TCDD)
Insecticides; pesticides; 
fungicides; herbicides
Prostaglandins Phthalates, COX inhibiting 
pharmaceuticals
Soft plastics, paints, inks; 
prescription pharmaceuticals
 
Table 1. Overview of exogenous steroid  mimetics. Exogenous endocrine mimetics have been 
reported to have agonistic and/or antagonistic behavior in mammals. Exposures to these 
compounds occur through various types of materials in a variety of settings. 
and renal protective component that is attenuated during post-menopausal state (Rubinow 
& Girdler, 2011;Ojeda et al., 2007a). But, estrogen differences between the sexes cannot alone 
explain the disease development differences because androgens have been observed to have 
cardioprotective properties as well (Manolakou et al., 2009). 
Androgens are important in fetal development regardless of sex. During the first trimester 
of development, the male fetus maturation is dictated by the presence of androgens, which 
if disrupted can lead to several conditions such as testicular cancer, lower sperm count and 
motility, and cryptorchidism (Manikkam et al., 2004;Bormann et al., 2011;Recabarren et al., 
2008). With below-normal levels of testosterone, the male fetus fails to properly develop the 
testes, known as testicular dysgenesis. In contrast, excess testosterone is linked to altered 
development of the seminiferous tubules and lower sperm count and motility. Taken 
together these studies show proper control of androgen levels in males is essential to normal 
reproductive development (Manikkam et al., 2004;Bormann et al., 2011). 
In growth restricted males, increased testosterone levels have been shown to lead to an 
increase in angiotensin II sensitivity and this in turn may lead to increased susceptibility to 
hypertension (Ojeda et al., 2010). Recently, Ojeda et al. showed high incidence of 
hypertension coinciding with growth restriction is dependent on circulating testosterone 
levels. The castration of adult growth restricted males resulted in mitigation of the 
hypertension, which contrasted the observations of no blood pressure change after 
castration of normal growth, hypertensive male rats (Ojeda et al., 2007a).  
The concept of endocrine disruption leading to developmental programming can be 
extended to the fetal renin-angiotensin system (RAS) as well. Interestingly, this system is 
responsive not only to pharmacological manipulation but also to nutritional stress as well. 
Indeed, work from several laboratories has provided insights regarding the role of the RAS 
in cardiac development (Beinlich et al., 1991;Beinlich & Morgan, 1993;Beinlich et al., 
1995;Samyn et al., 1998;Segar et al., 1997;Segar et al., 2001;Sundgren et al., 2003). In particular, 
Sundgren et al. demonstrated that Ang II promotes hyperplastic growth during early 
gestation, whereas Beinlich et al. have reported neonatal hypertrophic growth in the pig 
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(Beinlich et al., 1995;Sundgren et al., 2003). The intra-cardiac RAS also appears to be sensitive 
to nutritional stress as demonstrated recently by Gilbert et al. in a study that shows 
decreased immunoreactive AT1 and AT2 in the mid-gestation left ventricle of fetal sheep 
gestated in ewes that were subjected to 50% global nutrient restriction (Gilbert et al., 2005b).  
3.2 Exogenous hormones/mimetics/antagonists 
Exposure to a variety of environmental factors may generate exogenous interference with 
endocrine systems through mimetic or antagonistic activity. This is a rapidly growing area 
of research with implications for both environmental and public health. Several known 
exogenous estrogen antagonists include polychlorinated (PCB) and polybrominated (PBB) 
biphenyls, dichlorodiphenyltrichloroethane (DDT), methoxychlor, diethylstilbestrol, 17ǃ-
estradiol, alkylphenols sewage degradation, cadmium, and the infamous bisphenyl-A (BPA) 
(Sonnenschein & Soto, 1998;Derfoul et al., 2003). Xenoestrogens may exist in the system at 
levels that do not elicit strong or detectable estrogenic effects individually, but it has been 
shown that these have additive effects and several xenoestrogens in the system can act 
together to induce estrogenic activity. (Sonnenschein & Soto, 1998) This additive effect brings 
rise to the idea that some materials we are exposed to may pass inspection individually for 
tolerable levels of these endocrine disrupting compounds, but in concert with low levels of the 
xenoestrogens may have phenotypic effects in utero. Since estrogen is mainly required in 
maturation and growth, it is common to not see congenital endocrine complications until 
adolescence or even as late as adulthood (Derfoul et al., 2003). Overexposure of estrogens to 
the fetus has been suggested to stunt growth and alter bone development (Derfoul et al., 
2003;Sonnenschein & Soto, 1998). In contrast to the large number of estrogen disruptors, only 
several androgen antagonists have been identified and studied. These are insecticide 
ingredients such as kepone and procymidone, dichlorodiphenyldichloroethyle (DDE), 
vinclosolin, and 2,3,7,8-tetrachlorodibenzodioxin (TCDD) (Sonnenschein & Soto, 1998). While 
very little to no androgen agonists have been discovered (Sonnenschein & Soto, 1998) it has 
been reported that exposure to androgen antagonists like DDE is linked to development of 
recurrent respiratory tract infection (Carey et al., 2007).  
Prostaglandins are important to many sexual processes in both men and women, but little 
has been done on that research to describe endocrine disruption targeting prostaglandins. 
Interference in prostaglandin pathways has been associated with the development of several 
types of cancer and cardiovascular disorders. The alteration of synthesis of prostaglandins 
from arachadonic acid through the COX enzyme has been shown disrupt endocrine 
processes. Several phthalates that are similar to pharmaceutical COX inhibitors, were found 
to disrupt the levels of prostaglandin synthesis (Kristensen et al., 2011). Chronic inhibition of   
COX activity is known to have deleterious effects on renal and cardiovascular function, 
resulting in mild to moderate hypertension and even renal failure. Developmental sex 
differences in this system have been reported and show that renal COX-2 expression is 
higher in female fetuses at gestational day 21 than age matched male fetuses (Baserga et al., 
2007a).  Prostaglandin synthesis pathways are relatively understudied but may provide 
important insights into the development of sex differences in adult disease.  
4. Sex differences in developmental programming  
Numerous studies have documented sex-differences in the incidence and severity of 
cardiovascular diseases such as coronary artery disease, heart failure, cardiac hypertrophy, 
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and sudden cardiac death (Gilbert et al., 2006b;Ojeda et al., 2008;Grigore et al., 2008). These 
differences in the expression of cardiovascular disease may be related in part to intrinsic sex-
differences in myocardial function. Many recent studies have provided evidence that 
indicates a sex dichotomy also exists in the physiological responses to developmental 
challenges as they relate to the programming of subsequent cardio-renal function. These 
studies have largely been interpreted in one of two ways: 1) that male and female fetuses 
adapt differently to developmental stressors; or 2) that male and female sex steroids have a 
profound influence on the development and progression of developmentally programmed 
disease states. Moreover, since sex differences are apparent quite early in embryonic 
development and are independent of sex hormones; developing a third line of reasoning to 
suggest innate differences between the sexes play a role in the response of the developing 
organism to stressors may yield useful insights. Viewed in concert several primary 
remaining questions emerge: Do innate sex differences originating in fetal life predispose 
organisms to adult diseases in general and developmentally programmed outcomes in 
particular? Do post-natal sex differences drive specific fetal adaptations to in utero stressors 
that generate differential outcomes? Or perhaps it is a combination of these scenarios? 
4.1 Human studies 
A small number of clinical studies have investigated sex differences in renal function as it 
relates to developmentally programmed hypertension. The larger body of work in this area 
has detailed differences in cardiovascular parameters and stress responses. Nevertheless, 
several interesting findings have been reported that confirm the idea that women are “reno-
protected” during early adulthood. A recent report from the Nord Trøndelag Health Study 
(1995-1997) in Norway found intrauterine growth restriction (IUGR), high blood pressure 
and low normal renal function were associated in 20-30 year olds (Hallan et al., 2008). 
Although the degree of impaired renal function was small in these young adults, it was 
significant and more consistent in men than women (Hallan et al., 2008). Similarly, Kistner et 
al. reported women born pre-term had increased blood pressure but no signs of adverse 
renal function as young adults (Kistner et al., 2000).  
Other studies have evaluated cardiovascular responses between male and female subjects 
that were growth restricted in utero. In one such study, Ward and colleagues reported 
women born small were far more susceptible to stress-induced increases in systolic blood 
pressure (Ward et al., 2004).  A recent study by Jones et al. has shown that there are marked 
sex differences in the way size at birth is associated with alterations in cardiovascular 
physiology established in childhood (Jones et al., 2008). Further evidence that markers of 
impaired fetal growth are related to autonomic cardiovascular control involving modulation 
of both sympathetic and parasympathetic function but in a sex-specific manner has also 
been provided in an adult Australian cohort by the same group (Jones et al., 2007). The 
authors reported women, but not men, who were small at birth demonstrated increased 
low-frequency blood pressure variability at rest and during stress, reduced levels of high-
frequency heart period variability and a reduction in baroreflex sensitivity.  
4.2 Animal studies  
Studies utilizing animal models have employed a range of stressors in a variety of species to 
induce fetal growth restriction and test hypotheses regarding the developmental origins of 
disease (summarized in Table 2).  Perhaps the most common model to date has focused on 
maternal nutrient restriction (MNR), either as a decrease in total caloric intake or an 
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isocaloric decrease in protein content; studies to understand the consequences of maternal 
obesity from the DOHAD perspective are gaining (Grigore et al., 2008;Mcmillen & Robinson, 
2005;Gallou-Kabani et al., 2007;Khan et al., 2005;Khan et al., 2003;Taylor et al., 2004).  
 
 Programming Insult Species Adult outcomes reported in the literature
Maternal overnutrition Rat, mouse, sheep
Hypertension (females), reduced vascular 
compliance,  Endothelial dysfunction, 
aortic hypoplasia, decreased renal Na+, K+
ATPase activity, decreased locomotor
activity (female>male)
Maternal undernutrition Rat, sheep, baboon
Hypertension (male>female), growth 
restriction, altered expression of renin-
angiotensin system
Placental insufficiency Rat
Hypertension (male>female), growth 
restriction, glucose intolerance
Maternal renal 
insufficiency
Rat, rabbit Hypertension (female>male)
Ang II receptor 
inhibition
Rat
Hypertension, decreased nephron number, 
glomerulosclerosis (male>female),  
interstitial fibrosis (male>female)
Glucocorticoid excess Rat, sheep
Hypertension (sex and age dependent), 
glomerulosclerosis
Androgen excess
Rat, mouse, sheep, 
human
Hypertension  (male>female), decreased 
endothelial function, ovarian dysgenesis, 
increased ANG-2 sensitivity (GR males), 
increased male-like sexual behavior 
(female), growth retardation, delayed 
vaginal opening, increased aggression
Estrogen deficiency
Rat, mouse, sheep, 
human
Hypertension (postmenopausal women),  
infertility,  abnormal mammary growth
 
Table 2. Summary of developmental programming studies and outcomes. A variety of 
developmental insults lead to long-term health consequences for the offspring. (References 
found in Sections 2 and 3.) 
4.2.1 Models of nutrient restriction 
Others have shown that considerable sex differences are observed in the response to MNR 
between male and female baboon fetuses near term (Cox et al., 2008). Evidence from MNR 
studies suggest female progeny are less affected than their male siblings (Ozaki et al., 
2001;Woods et al., 2005;McMullen & Langley-Evans, 2005b;McMullen & Langley-Evans, 
2005a) although these observations may depend on the extent of the nutrient restriction 
(Hoppe et al., 2007). These studies generally show decreased nephron endowment and 
altered expression of components of the intra-renal renin-angiotensin system (Ozaki et al., 
2001;Woods et al., 2005;McMullen & Langley-Evans, 2005b;McMullen & Langley-Evans, 
2005a;Hoppe et al., 2007). Hemmings et al. have reported impairment of the myogenic 
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response in the mesenteric vascular bed of pregnant adult females exposed to MNR during 
development (Hemmings et al., 2005). MNR during the pre-implantation period in the rat 
resulted in elevated BP in male offspring only (Kwong et al., 2000). Restriction of specific 
nutrients other than protein has also been evaluated. A maternal low-sodium diet in rats has 
recently been associated with increased maternal plasma renin activity and correlated with 
IUGR, increased blood pressure, and reduced creatinine clearance in female offspring but 
not in males (Battista et al., 2002).  
Similar to the results observed in many small animal models, not all large animal models 
show clear effects of MNR on the offspring. In addition, only a subset of these studies has 
been evaluated for sex differences. Previous work has shown male sheep and baboon 
fetuses are more susceptible to the effects of poor maternal nutrition (Gilbert et al., 
2005a;Gilbert et al., 2006a;Gilbert et al., 2007a). Studies in sheep have shown global caloric 
restriction impairs nephrogenesis and alters intrarenal immunoreactive AT1, AT2 and renin 
expression in gestational age and gender specific ways (Gilbert et al., 2007a). Further, only 
male offspring of these NR ewes are hypertensive (Gilbert et al., 2005a). While the 
mechanisms by which NR alters gene expression remains unclear in our model, data from 
Lillycrop et al. and Burdge et al., both employing protein restriction in the rat suggests 
deficiency of methyl donors may alter gene methylation patterns and in turn effect changes 
in gene expression (Lillycrop et al., 2005;Burdge et al., 2007;Lillycrop et al., 2007;Lillycrop et 
al., 2008). It remains unclear whether the increased risk to the males is a result of gene-
environment interactions originating during or after gestation. Further studies are needed to 
thoroughly investigate these possibilities.  
4.2.2 Models of utero-placental and renal insufficiency 
Models of utero-placental insufficiency are quite intriguing as they are relevant to multiple 
maternal health issues as well as to the developmental programming of hypertension.  
Alexander et al. have shown that reduced uterine perfusion pressure during the last 
trimester of pregnancy in the rat programs hypertension in the offspring and in a sex 
specific manner (Grigore et al., 2007;Alexander, 2003). Further, in this model both the RAS 
and sex steroids have been implicated in the observed sex differences in hypertension 
(Ojeda et al., 2007b;Ojeda et al., 2007a;Grigore et al., 2007).  In contrast, the two kidney-one 
wrapped kidney (2K,1W) model of hypertension resulted in hypertension in 30 week old 
female offspring only (Denton et al., 2003). Interestingly, plasma renin activity was 
significantly lower in the female offspring of hypertensive mothers at 10 weeks of age 
(P<0.05), suggesting that development of the renin-angiotensin system was altered. The 
differences in the factors elaborated by the ischemic placenta and poorly perfused kidney 
illustrate the complexity of the interactions between the maternal endocrine milieu and fetal 
development. Whereas reduced renal perfusion primarily activates the RAS, the ischemic 
placenta produces a variety of humoral and locally acting factors such as sFlt-1 (soluble fms-
like tyrosine kinase-1) and tumor necrosis factor (TNF)-ǂ that have far reaching effects.  
Recent studies in the rat and baboon have shown chronic reductions of utero-placental 
blood flow elevates levels of sFlt-1 in the placenta, amniotic fluid and maternal plasma 
(Gilbert et al., 2007b;Makris et al., 2007). In the rat, this has been associated with decreased 
fetal growth and subsequent hypertension that is sex dependent (Alexander, 2003;Ojeda et 
al., 2007a). Recent studies in rodents have shown elevated sFlt-1 levels alone results in fetal 
growth restriction (Lu et al., 2007b;Bridges et al., 2008). Furthermore, Lu et al. have followed 
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the mouse offspring of these pregnancies and reported sex specific effects regarding the 
development of hypertension as only male mice have higher blood pressure in this model 
(Lu et al., 2007a). Viewed together, these studies strongly suggest that in addition to the 
immediate well being of the mother, a long term outlook with regards to the well being of 
the fetus must also be considered during complicated and/or high risk pregnancies.  
4.2.3 Maternal obesity 
Maternal obesity is associated with a variety of conditions including maternal hypertension, 
hypertriglyceridemia, hyperglycemia and insulin resistance (Wilson & Grundy, 2003), that 
are independently correlated with a suboptimal in utero environment and consequently 
linked to DOHAD. Several human studies have described a positive correlation between 
maternal weight and/or adiposity and blood pressure of teenage children (Lawlor et al., 
2004;Cho et al., 2000;Laor et al., 1997), leading Boney et al  to conclude from their 
examination of large for gestational age babies and the incidence of childhood metabolic 
syndrome, that “given the increased obesity prevalence in children exposed to either 
maternal diabetes or maternal obesity, there are implications for perpetuating the cycle of 
obesity, insulin resistance, and their consequences in subsequent generations.” Few, if any, 
of the studies in humans include offspring sex as a co-variable (Boney et al., 2005).  
Important information with regard to maternal nutrient excess and sex-associated difference 
comes largely from animal models. Studies show hypertension in male rat offspring after 
exposure to a maternal diet high in saturated fat (or low in linoleic acid) that is not present in 
females (Langley-Evans, 1996). In contrast, Elahi et al. reported mice fed high fat diets long 
before the onset of gestation are hypercholesterolemic, hypertensive and produce 
hypertensive, hypercholesterolemic female offspring (Elahi et al., 2008). Moreover, treatment of 
the dams with pravastatin lowered blood pressure and cholesterol levels in those offspring 
(Elahi et al., 2008). Because the numerous pleiotropic effects of statins the mechanisms for these 
effects remain unclear, nevertheless these observations provide insights for further studies. 
In a model more resembling high fat food consumption in humans, Armitage et al. 
demonstrated that a diet rich in fat fed to pregnant rats results in male offspring gaining 
more body weight and presenting with decreased renal renin activity when compared to 
females (Armitage et al., 2005). Offspring from this model are reportedly hypertensive, 
exhibit increased aortic stiffness, decreased aortic smooth muscle cell number, endothelial 
dysfunction and decreased renal Na+, K+-ATPase activity. The bulk of these changes were 
independent of sex except for increased blood pressure where female offspring were 
hypertensive while the males were not (Khan et al., 2003;Samuelsson et al., 2008). Further, 
Khan et al. reported female offspring have reduced locomotor activity at 180 days of age 
compared to male offspring of pregnant rats fed a high fat diet during pregnancy (Khan et 
al., 2003).  In addition, this research group used cross-fostering techniques after birth to 
show that the hypertension in females is attained whether exposure to maternal high fat diet 
occurs before and during pregnancy or during the suckling period (Khan et al., 2005). While 
the mechanisms responsible for programming due to high fat diets remain unclear, the 
report that statin treatment has beneficial effects on the offspring highlights at least one 
potential mechanism, alterations in lipid metabolism (Elahi et al., 2008). In addition, it has 
been suggested that high levels of butyric acid that may result from a high fat diet could 
lead to changes in chromatin structure and result in epigenetic alterations (Junien, 2006). 
Taken together these observations highlight an important role for nutrition and intermediate 
metabolites in developmental programming.  
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4.2.4 Endocrine disruption 
The importance of environmental exposures to endocrine disruptors during pregnancy has 
long been noted. Factors derived from Pinus ponderosa needles (e.g. isocupressic acid) and 
leaves from Veratrum californicum have long been observed to have profound impacts on the 
pregnancies of livestock (Short et al., 1995;Panter et al., 1992;Wu et al., 2002). Moreover, the 
observations that ingestion of Veratrum californicum by sheep at specific times of gestation 
resulted in fetal malformations and prolonged gestation laid the foundation for 
experimental evidence that supports a crucial role for glucocorticoids and the fetal 
hypothalamic pituitary axis in the onset of parturition (Liggins, 1994;Challis et al., 2000). 
Similarly, carbenoxolone, an active ingredient of licorice may also inhibit production of 
cortisol and disrupt normal HPA signaling between the mother and fetus. These findings 
point to a role for maternal and fetal stressors that alter glucocorticoid levels during 
pregnancy as important mediators of developmental programming. One such physiological 
stressor is exercise during pregnancy which has been reported to have a variety of effects on 
the offspring in hypertensive rats (Gilbert et al., 2008). Whereas moderate exercise lowered 
blood pressure in female offspring and increased body density in both male and female 
progeny, a high volume of exercise resulted in post-natal growth failure followed by catch-
up growth but only females suffered exacerbated hypertension (Gilbert et al., 2002). Using a 
dexamethazone injection model, O’Reagan et al. showed similar effects on BP in males and 
females but the magnitude of hypertension and a greater stress-induced hypertension was 
observed in males. In another study, prenatal dexamethasone (DEX) treatment significantly 
enhanced the arterial pressure response to acute stress only in female Wistar rats, while DEX 
augmented the elevation in heart rate during stress only in male rats (Bechtold et al., 2008).  
Ortiz et al. have shown antenatal DEX elevates blood pressure in female offspring at three 
weeks of age while only male offspring had increased blood pressure at six months of age 
(Ortiz et al., 2003). Interestingly, despite the observation only male DEX-treated rats were 
hypertensive at six months of age, both male and female offspring showed signs of 
glomerulosclerosis when compared to control rats (Ortiz et al., 2003).  Similar work has 
shown that a postnatal diet rich in ω-3 (n-3) fatty acids attenuates the effects of DEX on 
blood pressure in the offspring (Wyrwoll et al., 2006) in a sex independent manner. With the 
wide ranging effects reported in the glucocorticoid models, continued studies are required 
to tease out the mechanisms of sex-specific responsivity in this programming model. 
Another intriguing area of investigation garnering attention involves the role of the 
maternal RAS during pregnancy and/or lactation in pregnancy outcome and offspring 
health. These approaches may be in the form of administration of RAS inhibitors (Salazar et 
al., 2008) or altered sodium diet as described above (Battista et al., 2002). RAS inhibition at 
the level of the AT1 receptor is reported to have several sex specific effects that manifest 
post-partum (Loria et al., 2007b;Saez et al., 2007;Salazar et al., 2008). Saez et al. found that AT1 
inhibition reduces nephron number similarly in male and female rats, but the subsequent 
glomerulosclerosis and interstitial fibrosis are greater in males than in females. Further, the 
male rats are also reported to have a significant papillary atrophy (Saez et al., 2007). 
Functional differences include impaired urinary-concentrating ability during a prolonged 
dehydration in the male offspring (Loria et al., 2007b) and impaired excretory capacity 
following acute volume expansion (Loria et al., 2007a).  
Although the present data clearly indicate inhibition of the RAS during pregnancy has well 
defined and deleterious effects on renal development and function in the offspring, current 
studies are less clear on the effects of more subtle perturbations of the RAS (e.g. via dietary 
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alterations, etc.) on the long term health of the offspring. Further work in these areas will 
help define the importance of these pathways in the developmental programming of health 
and disease. 
5. Potential mechanisms underlying sex differences in developmental 
programming 
A variety of mechanisms have been postulated with regard to DOHAD (summarized in 
Figure 2). While the contribution of sex to the developmental origins of disease is widely 
recognized, it seems sex may exert distinctly different influences during fetal and adult life. 
For example, while male fetuses may be more susceptible to in utero nutrient privation 
(Gilbert et al., 2007a), female fetuses may have increased susceptibility to gestational over-
nutrition (Khan et al., 2003). The reasons for this remain nebulous; however, one clue may be 
held in the long observed differences in growth rates exhibited by male and female fetuses 
in utero (Parker et al., 1984). Hence, a faster growing male fetus may experience greater or 
lesser degrees of these nutritional insults compared to a female counterpart. Differences in 
the rate at which the male develops compared to the female likely contribute to gender 
differences in stress responses during pregnancy (Ozaki et al., 2001). It remains unclear 
whether male fetuses have increased metabolism compared to female fetuses. Hence, the 
 
Maternal environmental factors/stressors
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Fig. 2. Proposed mechanisms of sexual dimorphism in developmental programming. Research has 
revealed the dependence on the stimuli that result in normal development, but several 
connections are yet to be defined. Dark blue arrows with solid outline indicate observed 
pathways, like blue arrows with dotted outline represent putative connections. 
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chromosomal complement of the fetus may affect maternal metabolism and as the mother 
carrying a male fetus endures NR, the male fetus will face greater hardship than a female 
fetus in an equivalent pregnancy. In contrast, the female fetus in a pregnancy with an over-
nourished mother could face similar hardship via different pathways. 
5.1 Innate sex differences  
While the existence of sexually dimorphic phenotypes is rather obvious, the mechanisms 
that underlie this process have remained a matter of interest. Using a theoretical model to 
examine the evolutionary association between X-linkage and sexually dimorphic 
phenotypes, Rice concluded that “sex chromosomes facilitate the evolution of sexual 
dimorphism and that X-linked genes have a predominant role in coding for sexually 
dimorphic traits” (Rice, 1984). In the ensuing twenty-five years support for this thesis has 
grown to include functional grouping of X chromosome gene content. Genes expressed in 
brain (Zechner et al., 2001), for example, are particularly abundant on the X chromosome. In 
contrast, and perhaps of importance to potential paternal contributions to the interactions 
between fetus and the maternal environment, placentally expressed genes are relatively rare 
on the X chromosome (Ko et al., 1998).  
It has been recognized in humans that blood pressure is higher in men than in women (Burt 
et al., 1995) and this difference originates during adolescence and persists into adulthood 
(Yong et al., 1993). Further, males show an enhanced propensity to progress towards renal 
injury and decreased renal function than do females in several species (Neugarten et al., 
2002;Reckelhoff et al., 1998;Sandberg & Ji, 2003). Although the roots of this difference have 
been linked to the RAS (Miller et al., 1999), a role for an alteration in the ratio of sex steroids 
has also been proposed. Androgens have been linked with the progression of renal injury 
(Reckelhoff et al., 1998;Sandberg & Ji, 2003) while estrogens have been proposed as being 
protective of renal function (Sandberg & Ji, 2003). Moreover, it seems that sex may exert 
distinctly different influences during fetal and adult life. Whereas male fetuses may be more 
susceptible to in utero nutrient privation (Gilbert et al., 2007a), female fetuses appear to have 
increased susceptibility to gestational over-nutrition (Khan et al., 2003). The reasons for this 
are not clear; however, one clue may be held in the long observed differences in growth 
rates exhibited by male and female fetuses in utero (Parker et al., 1984). Despite findings that 
seem to clearly identify sex hormones as a likely culprit, recent efforts have raised many 
further questions and much remains unclear regarding the role of innate sex vs. sex steroids 
in developmental programming. 
5.2 Epigenetic mechanisms 
Epigenetic phenomena appear to be central to the induction of persistent and heritable 
changes in gene expression that occur without alteration of DNA sequence (Akintola et al., 
2008;Bird, 1986;Holliday & Ho, 2002;Wyrwoll et al., 2007). While most cells in an organism 
contain the same DNA, gene expression varies widely across various tissues. Epigenetic 
mechanisms underlie this tissue- and cell-type-specific gene expression (Waterland & 
Michels, 2007) and include CpG methylation, histone modification (acetylation) and the 
activity of autoregulatory DNA-binding proteins (Kelly & Trasler, 2004). Moreover, since 
DNA methylation and histone acetylation are implicated in the silencing of gene expression, 
X-inactivation and X-linked dosage differences (Chow et al., 2005), one might argue that sex-
bias in differential gene expression linked to DOHAD also has its roots in methylation. 
Indeed, these processes appear to have many sex specific features.   
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Because moderate folate depletion can induce genome-wide DNA methylation (Jacob et al., 
1998), genomic methylation may be useful as an integrative biomarker of methyl donor 
nutritional status (Mason, 2003). While considerable work has been initiated in this area 
with regards to developmental programming, little work has focused specifically on sex 
differences. Interestingly, sheep exposed to a methyl deficient diet during pregnancy 
produce hypertensive male offspring compared to females of similar rearing, as well as to 
male and female controls (Sinclair et al., 2007).  The authors then evaluated 1400 CpG sites 
(primarily gene promoter associated) in fetal liver at 90 days of gestation (term=150d) and 
reported that more than half of the affected loci were specific to males. These observations 
suggest male-specific demethylation that could provide a mechanistic basis for the 
phenotypic sex differences observed in that study (Sinclair et al., 2007).  In addition, the 
emerging fields of nutrigenetics and metabolomics (Mutch et al., 2005;Goodacre, 2007) seem 
poised to shed further light on these operational characteristics of these mechanisms. 
Alternatively, it has also been hypothesized that when genes are expressed in multiple 
tissues or serve several functions they should show less sex bias than genes that are more 
specialized (Ellegren & Parsch, 2007). The genes such as those involved in the RAS are 
certainly expressed in multiple tissues, yet these genes are also closely associated with sex 
differences in the developmental origins of cardio-renal diseases. Clearly there is a 
tremendous gap in our understanding of these complex topics and further studies are 
needed to clarify these matters particularly in the light of the differences reported regarding 
fetal gender and the developmental response to maternal over- and under-nutrition. 
5.3 Sex steroids 
In contrast to the sex-related dichotomy observed in response to nutritional stressors, when 
faced with a robust stressor such as AT1 antagonism (Loria et al., 2007a;Loria et al., 2007b;Saez 
et al., 2007;Salazar et al., 2008), severe protein restriction (Woods et al., 2001), or chronic 
reductions uterine perfusion pressure (Ojeda et al., 2007a;Alexander, 2003) both male and 
female fetuses are affected similarly in utero. Nonetheless a dichotomy emerges later in life 
with females being less impacted by their suboptimal in utero experience (Loria et al., 
2007a;Loria et al., 2007b;Saez et al., 2007;Salazar et al., 2008). The apparent benefit of being 
female in scenarios such as this are supported by recent work that suggested estrogens confer 
a protective effect on intrauterine growth restricted females that prevents the development of 
programmed hypertension (Ojeda et al., 2007a). Moreover, the observation that ovariectomy 
leads to a significant increase in blood pressure in growth-restricted females with no 
significant effect in controls makes a strong case for the post-developmental involvement of 
estrogens. Indeed, estrogen replacement reversed the effect of ovariectomy on blood pressure 
in growth-restricted offspring as did renin angiotensin system blockade (Ojeda et al., 2007a). 
Studies on the role of sex hormones in expression of components of renal renin angiotensin 
in healthy Sprague Dawley rats, have suggested that an estrogen-mediated attenuation of 
renal AT1 binding is a potential mechanism by which estrogen exerts protection from 
vascular and renal disease in females (Rogers et al., 2007). When this inhibition is lifted 
following ovariectomy in their model, or in diabetes or menopause, the resulting increased 
angiotensin II signaling increases both the degree of susceptibility to vascular and renal 
disease and the rate of existing disease progression (Rogers et al., 2007). 
Testosterone has also been implicated in the progression of hypertension in male growth 
restricted offspring (Ojeda et al., 2007b). The potential underlying mechanisms have been 
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studied by Sullivan (Sullivan et al., 2007) who has described a relationship between 
androgens and the development of albuminuria, and the renal protection afforded by 
estrogen, in spontaneously hypertensive rats. There is some evidence to suggest that both over 
activity of the renin angiotensin system and oxidative stress likely contributing to sex 
differences in the progression to renal injury. Treatment with either an AT1 blocker and/or an 
ACE inhibitor blunts the occurrence of renal injury in males (Lazaro et al., 2005). Male 
spontaneously hypertensive rats (SHR), which exhibit some signs of a programming model 
such as smaller size at birth when compared to Wistar-Kyoto control rats, exhibit androgen-
dependent increases in blood pressure and albuminuria that are independent of renal cortical 
angiotensin II levels and oxidative stress (Sullivan et al., 2007). In contrast, a female specific 
form of hypertension during pregnancy, preeclampsia, is reportedly not to be influenced by 
the levels of circulating testosterone levels during pregnancy (Tuutti et al., 2011). 
Interestingly, the cardio-renal protective effects of estrogens has not been a universal finding 
(Salazar et al., 2008). Considering the differences between the models employed by different 
laboratories, one possibility could be the magnitude of the insult to the kidney during 
development has an influence on the extent of protection that may be afforded by female sex 
hormones in later life. It is widely recognized that differences in sex hormones contribute to 
considerable sexual dimorphism in the transcriptome of a variety of mammalian tissues and 
organs (Rinn & Snyder, 2005); however, it has only recently been recognized that 
androgen/estrogen independent mechanisms may operate at the transcriptional level to 
regulate sex differences (Tullis et al., 2003). This possibility represents an alternate pathway 
that may be at work contributing to the observations that the relationship between sex 
hormones and blood pressure is far more complex than simply the balance of estrogen vs. 
testosterone (Ojeda et al., 2007a). Taken together, it appears that the influence of sex on the 
developmental origins of disease may reach far beyond the widely recognized role of sex 
hormones. Alternatively, recent work implicates growth hormone (GH) in sex dependent 
differences in renal expression of glomerular AT1 during hypertrophy following 
uninephrectomy; male rat kidneys show increased glomerular AT1 expression, whereas 
females do not (Mok et al., 2003). Because there is sexual dimorphism in GH release these 
observations may hold implications for both normal and pathological growth and 
development of the kidney.  
6. Concluding remarks 
From a clinical perspective it is hoped that increased understanding and awareness of 
developmental programming will lead to better diagnostic, preventative and therapeutic 
measures. The persistence of programmed effects is likely due to covalent modifications of 
the genome resulting from changes in promoter methylation and histone acetylation. The 
emerging fields of metabolomics and nutrigenetics suggest many of these alterations are 
likely a result of changes in the metabolic flux during critical periods of development. While 
epigenetic phenomena are central to the induction of persistent and heritable changes in 
gene expression that occur without alteration of DNA sequence, their contribution to the 
intensively studied sex differences in developmental programming remains uncertain. 
While reversal of these molecular changes may be possible and to improve long-term health 
outcomes if interventions are timed appropriately, loss of function in existing structures 
may be difficult to overcome if developmental plasticity is no longer present. For example it 
is difficult to see how any deficit in nephron endowment can be remedied. Nevertheless, 
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continued investigation using hypothesis driven mechanistic studies that incorporate sexual 
dimorphism into the models rather than attempt to control for sex differences by omitting 
male and/or female subjects are needed to identify target pathways for possible 
intervention. 
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